Skip to main content

Immunogen appoints Sayare to CEO


NEW YORK Biotech company Immunogen has appointed a new CEO.

The company announced that Mitchell Sayare would leave the company, and Daniel Junius would replace him.

Immunogen focuses on antibody-based cancer biologics and works with companies such as Biogen Idec, Bayer Health Care and Sanofi-Aventis.

This ad will auto-close in 10 seconds